Index of reports
> Cases with Infection (3)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Fluorescite (Fluorescein Ophthalmic) where reactions include infection. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Fluorescite side effects in 66 year old male
Reported by a health professional (non-physician/pharmacist) from China on 2012-06-05
Patient: 66 year old male
Reactions: Nausea, Fear, Hypotension, Coma, Anaphylactic Shock, Stupor, Abdominal Pain Upper, Hypoxic-Ischaemic Encephalopathy, Renal Failure, Respiratory Arrest, Cardiac Arrest, Infection
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Fluorescite
Possible Fluorescite side effects in 67 year old male
Reported by a physician from Japan on 2011-11-02
Patient: 67 year old male, weighing 67.0 kg (147.4 pounds)
Reactions: Haemophilus Infection, Pyrexia, Haemodialysis, Conjunctivitis Bacterial, Renal Impairment, Dehydration, Decreased Appetite, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Fluorescite
Dosage: 250 mg milligram(s), qd, intravenous
Indication: Diagnostic Procedure
Start date: 2011-09-15
End date: 2011-09-15
Pletal
Dosage: 100 mg milligram(s), bid, oral
Administration route: Oral
Indication: Renal Impairment
Start date: 2011-09-17
End date: 2011-09-21
Pletal
Dosage: 100 mg milligram(s), bid, oral
Administration route: Oral
Indication: Arteriosclerosis Obliterans
Start date: 2011-09-17
End date: 2011-09-21
Other drugs received by patient: Diovan; Neoral; Atelec (Clinidipine); Mucodyne (Carbocisteine); Fluvastatin; Basen (Voglibose); Newtolide (Hydrochlorothiazide); Cellcept
Possible Fluorescite side effects in 67 year old male
Reported by a physician from Japan on 2011-10-25
Patient: 67 year old male, weighing 67.0 kg (147.4 pounds)
Reactions: Transplant Rejection, Upper Respiratory Tract Inflammation, Conjunctivitis Bacterial, Renal Impairment, Dehydration, Decreased Appetite, Cough, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pletal
Dosage: 100 mg milligram(s), bid, oral
Administration route: Oral
Indication: Arteriosclerosis Obliterans
Start date: 2011-09-17
End date: 2011-09-21
Pletal
Dosage: 100 mg milligram(s), bid, oral
Administration route: Oral
Indication: Renal Impairment
Start date: 2011-09-17
End date: 2011-09-21
Fluorescite
Dosage: intravenous
Start date: 2011-09-15
End date: 2011-09-15
Other drugs received by patient: Fluvastatin; Diovan; Cellcept; Newtolide (Hydrochlorothiazide); Basen (Voglibose); Mucodyne (Carbocisteine); Atelec (Clinidipine); Neoral
|